Chief Financial Officer
Andrew Buckland is Polynoma’s Chief Financial Officer and is responsible for financial operations. Mr. Buckland joined Polynoma in 2012. He earned an MBA from the University of California, Irvine and holds a BA (with Honors) from the University of the West of England. Mr. Buckland has extensive experience in the development of financial operations within both large multinational corporations and early to mid-stage companies, and has been the most senior financial officer of a number of U.S. public and pre-IPO life sciences companies. Prior to joining Polynoma, Mr. Buckland served as Chief Financial Officer of PURE Bioscience, Inc., a company he took from the OTC Bulletin Board to the NASDAQ Stock Market; as Vice President of Finance at Cardionet, Inc.; as Chief Financial Officer of Advanced Tissue Sciences, Inc., a NASDAQ-listed public biotechnology company; and in significant international accounting and financial management positions at Bristol-Myers Squibb and United Parcel Service.